Diagnos Inc. DGNOF

DGNOF Company Overview

Diagnos Inc. is a Canada‑based medical technology company operating in the healthcare diagnostics and digital health industries. The company focuses on the early detection and screening of eye diseases, particularly those related to retinal health, using advanced image analysis and artificial intelligence. Diagnos’ core value proposition is improving access to preventative eye care while reducing costs and clinical burden through automated diagnostic support tools.

The company’s primary revenue driver is its proprietary CARA retinal analysis platform, which analyzes retinal images to identify risk indicators for conditions such as diabetic retinopathy and age‑related macular degeneration. Diagnos serves eye care professionals, clinics, hospitals, and public health screening programs, with a strategic emphasis on large‑scale population screening. Founded in the late 1990s, the company originally focused on hardware‑based ophthalmic imaging and progressively evolved toward software‑driven, AI‑enabled diagnostics, aligning its strategy with the growing demand for scalable tele‑ophthalmology solutions.